Beijing Weighs Curbs on the AI Models Americans Love

Summary

WSJ What’s News – Episode Summary

Episode Title: Beijing Weighs Curbs on the AI Models Americans Love
Date: July 9, 2026
Host: Daniel Bach (for The Wall Street Journal)

---

Episode Overview

This episode of WSJ What’s News rounds up the day’s most pressing stories in business, tech, and politics. Major topics include the tightening grip China may exert over AI models popular with American businesses, a shakeup in Maine’s Senate race, the AI-fueled boom in San Francisco’s housing market, shifting US biotech leadership, waning faith in core American ideals, and the fierce battle for dominance in the health-tech wearables market.

---

Key Discussion Points & Insights

1. Maine Senate Race Shakeup

• Summary: Populist Democratic candidate Graham Platner suspends his campaign after a sexual assault allegation, which he denies. He cites pressure from both the media and Democrats, not the accusation itself, for his exit.

• Implications: Democrats are left scrambling to name a new candidate by July 27, with party control of the Senate hanging in the balance.

• Notable Quote:

  • "This is incredibly difficult because I know that some will think it's an admission of guilt and it most certainly is not. We're not doing it because of the allegations. We're doing it because of the structures that are being taken away from us by those in power."
    — Graham Platner, [01:27]

• Analysis:

  • Aaron Zitner, WSJ editor, notes the importance of Maine: “Any path to taking a majority in the Senate next year runs through Maine. That was supposed to be the easiest of the four seats they need to gain.” [02:01]
  • If Democrats lose Maine, their path to the Senate majority must run through tougher Republican states like Texas and Ohio.

---

2. US-China Tensions Over AI Models

• Background: American businesses, especially in Silicon Valley, are increasingly reliant on inexpensive Chinese AI models such as DeepSeq and Moonshot AI for specific business tasks.

• Beijing’s Shift:

  • At first, China viewed the spread of its AI as a form of soft power. Recently, however, security concerns have grown over sharing technology that might empower adversaries.
  • Notable Quote:
    • "American businesses have been adopting them because they cost a lot less to run. But now Beijing's concerned that sharing some of this technology could help adversaries or malicious actors against China."
      — Sam Scheckner, [00:44], [03:10]

• Business Impact:

  • Companies often "switch" their AI queries between expensive US models (for sophisticated tasks) and cheaper Chinese alternatives (for routine processing).
    • “There’s a brewing price war around AI models... the complex ones might go to an American model, and more routine ones... to cheaper Chinese models.”
      — Sam Scheckner, [03:46]

---

3. Security Backdoors & AI Model Distillation

• Incident:
  • China announced security "backdoor vulnerabilities" in Anthropic's Claude code tool, urging users to update or uninstall. This followed Reddit posts suggesting “secret” code was identifying Chinese users.
  • Anthropic responded that this was an anti-abuse experiment, not espionage.
• Corporate Response:
  • Companies like Alibaba banned the use of US tools like Claude code amid model "distillation" accusations—training new models on the outputs of US models.

---

4. Biotech Competition Heats Up

• Trends:
  • China’s low costs, regulatory efficiency, and large trial populations fuel its biotech innovation engine.
  • US venture capitalists are investing heavily in AI-driven health startups aiming to speed up clinical trials.
    • “Companies are going to be looking for technological solutions... AI that plugs into medical records... or helps simulate research and plan trials.”
      — Brian Gormley, [05:39]
• US Prospects:
  • Many US firms conduct trials in China to save time and money, but some policymakers see this as a threat to American leadership in biotech and seek regulatory reforms.
    • “Policymakers and regulators... realize that clinical trials run better or often run faster and lower costs outside the United States. And that is making it harder for the United States to maintain its leadership in the biotechnology industry.”
      — Brian Gormley, [06:55]

---

5. SF Housing Market Soars on AI Wealth Boom

• Trend:
  • Anticipated IPOs from firms like OpenAI and Anthropic are driving a speculative frenzy in San Francisco real estate.
  • Single-family home prices up 22% year-over-year (May 2025 to May 2026).
    • “The city has become the Wild West of home buying as people try to front run anticipated IPOs.”
      — Daniel Bach, [07:18]

---

6. Airbnb Expands Despite Regulation

• Story:
  • Airbnb, fighting NYC rental restrictions, purchases a $81.5 million landmark building in Manhattan, signaling commitment to the city despite regulatory challenges.

---

7. Americans’ Eroding Faith in Capitalism and Democracy

• Poll Findings:
  • WSJ/NORC survey shows deep pessimism about US institutions and the “American Dream.”
  • Fewer than half say capitalism is working “even somewhat well.”
  • Only minorities believe the US is living up to ideals like equality, law above all, and effective democracy.
    • “We found that fewer than half of Americans say that capitalism is working even somewhat well... We're not feeling very good about America.”
      — Aaron Zitner, [09:53]
  • 62% of respondents believe America's best days are behind it.
    • “We’re almost united in our dissatisfaction... 62% said the best days of America are behind it.”
      — Aaron Zitner, [11:10]

---

8. The Battle for Health Tech Wearables

• Market Moves:
  • WHOOP recruits a high-profile Nike marketer as it eyes an IPO, hoping to challenge heavyweights like Apple Watch, Fitbit (Google), and Oura.
  • Debate over whether wearables (hardware + subscription model) are sustainable businesses.
    • Stephanie Davis, health tech analyst:
      • “Do I think any of these wearables are a sustainable business model? Longer term, no. ...But it’s always a question of timing.” [12:48]
      • Cautions retail investors to be wary of hype, as seen in the trajectory of Fitbit’s stock.

---

Notable Quotes & Memorable Moments

| Time | Speaker | Quote | |---------|-------------------|----------------------------------------------------------------------------------------| | 01:27 | Graham Platner | "This is incredibly difficult... We're not doing it because of the allegations..." | | 02:01 | Aaron Zitner | "The collapse of the Platner campaign is a big problem for the Democratic Party." | | 03:10 | Sam Scheckner | "American businesses have been adopting them because they cost a lot less to run..." | | 03:46 | Sam Scheckner | "There's a brewing price war around AI models. Tokens are expensive..." | | 05:39 | Brian Gormley | "Companies are going to be looking for technological solutions to improving clinical research..." | | 06:55 | Brian Gormley | "Policymakers and regulators in the United States realize that clinical trials run better or often run faster and lower costs outside of the United States..." | | 09:53 | Aaron Zitner | "We found that fewer than half of Americans say that capitalism is working even somewhat well..." | | 11:10 | Aaron Zitner | "We're almost united in our dissatisfaction... 62% said the best days of America are behind it." | | 12:48 | Stephanie Davis | "Do I think any of these wearables are a sustainable business model? Longer term, no..." |

---

Detailed Timestamps for Key Stories

• [00:33] — Episode headlines
• [01:17] – [02:33] — Maine Senate race shakeup analysis
• [03:10] – [04:23] — China mulls restricting AI exports, security concerns, price war details
• [04:23] – [06:14] — Anthropic security flap, model distillation, US-China AI rivalry
• [06:14] – [07:18] — US biotech firms using China for clinical trials; policy implications
• [07:18] – [08:44] — San Francisco housing market, Airbnb’s move, Trump court update
• [09:34] – [11:35] — Poll: Americans' declining confidence in democracy/capitalism
• [11:35] – [13:24] — The race to dominate health tech wearables, industry risks

---

Episode Takeaways

• Global AI and Tech: US businesses’ reliance on Chinese AI is facing a regulatory squeeze as Beijing reassesses its tech exports. This underlines ongoing friction over technology and security between China and the US.
• Domestic Politics: The sudden void in Maine’s Senate race has national implications for Democratic hopes of flipping the Senate.
• Real Estate & Innovation: AI-driven wealth anticipation is distorting housing markets: specifically, speculation around tech IPOs is fueling sharp price increases in San Francisco.
• Cultural Mood: Survey data reflects broad pessimism about the country's future and declining faith in core American values.
• Investment Trends: The wearables market is growing but faces questions over long-term profitability, with retail investors advised to temper their expectations.

---

For further reading and fuller details, check the WSJ show notes linked in the episode.

Transcript

[ReliaQuest Advertiser]

This podcast is brought to you by relioQuest. Cybercriminals are constantly attacking. They want your data. They want your identity. They want your innovation. RelioQuest fortifies your business with agentic defense AI that detects, contains and eliminates cyber threats in minutes. It helps your security team move faster at the work that matters most to protect the business now and delivers insights to help them predict what's next. ReliaQuest agentic defense for the enterprise. Learn more at reliaquest.com that's R E L I A Q U E-T.com

[Daniel Bach]

Maine's populist Senate candidate Grant Platner drops out of the race under heavy pressure from Democrats. Plus, China considers restrictions on the homegrown AI apps US companies are addicted to.

[Sam Scheckner]

American businesses have been adopting them because they cost a lot less to run. But now Beijing's concerned that sharing some of this technology could help adversaries or malicious actors against China.

[Daniel Bach]

And fears of an AI wealth boom in San Francisco fires up the housing market. It's Thursday, July 9th. I'm Daniel Bach for the Wall Street Journal, filling in for Luke Vargas. And here is the AM edition of what's News, the top headlines and business stories moving your world Today.

[Graham Platner]

We are suspending campaign operations.

[Daniel Bach]

Maine Democratic Senate candidate Graham Platner has ended his campaign following a sexual assault allegation which he fiercely denies.

[Graham Platner]

This is incredibly difficult because I know that some will think it's an admission of guilt and it most certainly is not. We're not doing it because of the allegations. We're doing it because of the structures that are being taken away from us by those in power.

[Daniel Bach]

In an 11 minute video, Platner blamed the media and party establishment for forcing him out of the race. His exit leaves state Democrats scrambling to find a replacement to challenge Republican incumbent Susan Collins on the November ballot. Journal editor Aaron Zittner says that losing this pivotal seat would complicate the Democrats path to winning back control of the Senate.

[Aaron Zitner]

The collapse of the Platner campaign is a big problem for the Democratic Party. Really, any path to taking a majority in the Senate next year runs through Maine. That was supposed to be the easiest of the four seats they need to gain in order to win a Senate majority. Under state law, the process for picking a new nominee falls to the Democratic State Committee, but we don't know yet what process they will use to select a nominee. We only know that they need to do it quickly. Under state law, they have until July 27th to name a new person and put that person's name on the ballot.

[Daniel Bach]

If the Democrats lose Maine but hope to win back majority in the Senate, they'd have to win several states such as Texas, Ohio and Iowa, normally considered solidly Republican. And we'll hear from Aaron later on in the show about how political polarization has had an impact on America's faith in democracy. If there's one common thread of the AI boom across corporate America right now, it's an addiction for cheaper Chinese models. In many cases, particularly in Silicon Valley, companies are saving money by using Deep seq or moonshot AI instead of models made by OpenAI and Anthropic.

[Sam Scheckner]

Until recently, China and the officials there wanted to encourage the rapid spread of Chinese AI models. Sort of saw it as a form of soft power, and that's been working. Some of these models perform close to the levels of proprietary American ones, and American businesses have been adopting them because they cost a lot less to run. But now Beijing's concerned that sharing some of this technology could help adversaries or malicious actors against China.

[Daniel Bach]

That's Journal tech reporter Sam Scheckner. He says Beijing is now considering tightening its grip on homegrown technology.

[Sam Scheckner]

What we've seen is that there's a brewing price war around AI models. Tokens are expensive and using the top tier models from Anthropic or OpenAI is costing companies lots of money. So what many of them are doing is using switchers or different technologies that kind of route different queries that they might be using internally in business processes where the complex ones, the higher end, you know, orchestrating queries might go to an American model that's expensive and more routine ones, or sub models running kind of parts of tasks will be routed to cheaper Chinese models.

[Daniel Bach]

At the same time, China said it has found what it called security backdoor vulnerabilities in several versions of Anthropic's popular Claude code tool, released between April and June. A government run cybersecurity platform said a built in monitoring mechanism could pose a serious threat and advise users to update or uninstall the software. The concern stem from a Reddit post last week that alleged Anthropic had secretly inserted code into the software to identify users who accessed it from China. In a response, an Anthropic employee said on X that the code was part of an experiment the American startup launched in March to prevent abuse from unauthorized resellers. Since February, Anthropic has accused Alibaba and several other Chinese AI labs of distilling its models, which is the practice of training a new model on the outputs of another Alibaba told its employees it will ban the use of Claude code at work from tomorrow. Competition is also heating up between the US And China in the biotech sector in China, streamlined regulation, increased insurance coverage for medicines, and the ease of recruiting patients for trials has turbocharged China's output of increasingly innovative drugs. And journal reporter Brian Gormley says American VCs are circling venture capitalists realize that

[Brian Gormley]

companies are going to be looking for technological solutions to improving clinical research, and they have been investing in companies that use artificial intelligence in various ways to make clinical studies run faster and better. For example, AI that plugs into electronic medical records to identify patients who can participate in a trial, or AI that helps simulate clinical research and helps researchers plan their trials. So there's a variety of ways that AI can be used to make clinical trials more effective and venture capitalists investing in a variety of different companies that are in that market.

[Daniel Bach]

Brian says China's innovation engine and lower costs has resulted in many US Companies looking to the country to run their

[Brian Gormley]

trials for companies in the United States. A lot of them would like to take advantage of the speed and efficiency of clinical trials in China, where patients can be recruited more quickly and at lower costs. So some are thinking about working with partners in China to conduct some of their clinical research there, generate some data, and potentially use that data as a springboard to launch clinical trials in the United States or globally.

[Daniel Bach]

Many see that turn to China, threatening US Leadership in the biotech industry, with venture capitalists among those pushing for regulatory changes from the Food and Drug Administration.

[Brian Gormley]

Policymakers and regulators in the United States realize that clinical trials run better or often run faster and lower costs outside of the United States. And that is making it harder for the United States to maintain its leadership in the biotechnology industry. And making clinical trials more effective in the United States is part of the strategy for us maintaining its leadership in that industry.

[Daniel Bach]

Last month, the FDA disclosed plans to accelerate clinical research, including a proposed pilot to speed initiation of human studies in San Francisco. Anxiety about the wealth that could be created in the next stage of the artificial intelligence boom has ignited the housing market. One real estate agent said the city has become the Wild west of home buying as people try to front run anticipated IPOs from OpenAI and Anthropic. That's pushed up prices of single family homes in San Francisco by around 22% between May 2025 and May of this year. Well, New York City tried to evict Airbnb, but the rental platform is putting down roots and buying a house to show there is no love lost. We're exclusively reporting that Airbnb is the mystery buyer of 281 Park Avenue South, a landmarked building near Gramercy park that sold for $81.5 million. The purchase comes as the company continues to lobby local and state officials to loosen the city's strict rules on short term rentals. And a New York federal judge has ordered President Trump to pay the $5 million in damages a jury awarded the writer E. Jean Carroll last week. The Supreme Court declined to hear the president's appeal of the defamation and sexual abuse verdict. Carroll's lawyers then asked a district court to order the immediate release of $5 million in damages, which is in a court supervised account and nearly $800,000 in interest. Trump's lawyers told the court that they would appeal. Coming up, is there a profitable future for health tech wearables? And Americans are losing faith in two cornerstones of the country's identity. Those stories after the break.

[ReliaQuest Advertiser]

Planning for retirement and all the things that go with it can be stressful. That's why Fisher Investments partners with you to understand your unique goals and needs so that they can build a tailored plan that helps you achieve a comfortable retirement. Whether you need help with financial planning, estate planning, tax optimization or Social Security, Fisher has specialists to help Fisher Investments. Now that's clearly different. Wealth management. Learn [e-mail] Investing in securities involves the risk of loss.

[Daniel Bach]

A new poll from the Wall Street Journal has revealed that confidence is eroding in the two main pillars of American society, capitalism and democracy. And Aaron Zitner leads our polling coverage and says the WSJ NORC survey shows a fracturing of long held beliefs in the so called American Dream.

[Aaron Zitner]

We set out to test some of the main elements of American national identity. How are folks feeling about the things that make us a nation? Democracy, capitalism, commitment to equality, a sense that there's something unique and even superior about this country compared to other countries. And we found that fewer than half of Americans say that capitalism is working even somewhat well, much less very well. People are pessimistic about the economy, pessimistic about the next generation, and very low shares said that the belief that no one is above the law, the belief that we have a fair judicial system, the belief that we're committed to democracy and majority rule, that those things describe America today either extremely well or fairly well. So, you know, the bottom line is we're not feeling very good about America.

[Daniel Bach]

Republicans in the survey stood apart in their belief in American exceptionalism, the long held idea that the US Is unique or superior among nations. But Overall, more than 2/3 of people were pessimistic about where the promise of the American dream stood today and the country's self image as a leader among nations.

[Aaron Zitner]

We're almost united in our dissatisfaction and we asked are the best days for America ahead of it or behind it? And 62% said the best days of America are behind it. And we found majorities of Republicans and very high shares of independents and Democrats agreeing there. We're kind of united in our grumpy mood about this country right now.

[Daniel Bach]

You can check out the full findings from the polling. We've left a link in our show notes and finally, the race is on to be the number one wearable. We're exclusively reporting that WHOOP is bringing on Nike marketing veteran Durkjan Van Hammeren to whip its brand into competitive shape as the company sets its sights on an IPO with WHOOP is up against big players like the Apple Watch, which accounts for more than half of new health tracking smartwatches, Google's Fitbit and Aura, which was valued at $11 billion last year and filed for its own IPO in May. But while many of the millions of Americans who wear a health tracker may be wondering what they'll be able to do with all that health data in the future and whether it will be used to sell them wellness plans or more services, investors are questioning whether those companies can be valuable.

[Stephanie Davis]

Fitbit when they first came out they had a hardware only model and then they acquired a health tech company one or two years in or so after they came public and they started trying to go and introducing a subscription because otherwise it's really easy to cannibalize your own revenues.

[Daniel Bach]

That's health tech analyst Stephanie Davis, who spoke to WSJ's take on the Week podcast to assess whether consumer health companies make a good investment.

[Stephanie Davis]

I think retail investor participation has changed in a dramatic fashion in the market. We've seen that with the SpaceX IPO, a lot of retail investors getting involved and there often are initial pops. Do I think any of these wearables are a sustainable business model? Longer term, no. And that's probably what that investor is saying. But it's always a question of timing. I think a lot of times a familiar product investors on the retail side like to get involved because it's something that they know and they have understanding of the look and feel. Don't forget Fitbit doubled before it drop down.

[Daniel Bach]

You can find the full conversation on the latest episode of WSJ. Take on the week. And while you're checking your sleep score, why not tap on your podcast app to set up a reminder for the latest episode of your favorite WSJ show. We're here to keep you up to date and in the green on news and current affairs. And that's it for what's news for this Thursday morning. Today's show was produced by Hattie Moyer. Our supervising producer is Sandra Kilhoff, and I'm Daniel Bock for the Wall Street Journal. We'll be back tonight with a new show. Until then, thanks for listening.

[Everpure Advertiser]

If your organization isn't managing its data with Everpure, then it's likely scattered all over the place.

[Fantasy Character]

Come on. Lord, for three days have I ridden

[Graham Platner]

to bring Thee warning.

[Fantasy Character]

The records thy great AI machine requires are strange. Cross five kingdoms.

[Everpure Advertiser]

Yeah, the Everpure data management platform unifies data so you can always find it. No messenger needed.

[Fantasy Character]

No more running around.

[Everpure Advertiser]

Get out of the data Dark ages with Everpure, a new era in data management.